Mucosal and Transmural Healing and Long-term Outcomes in Crohn's Disease.

endoscopy imaging mucosal healing

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 21 12 2023
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

Healing in Crohn's disease is complex and difficult to measure due to incongruencies between clinical symptoms and disease states. Mucosal healing (MH) and transmural healing (TH) are increasingly used to measure clinical improvement in Crohn's disease, but definitions of MH and TH can vary across studies, and their relationship to long-term outcomes is not clear. To address this knowledge gap, we performed a systematic literature review (SLR) to examine studies measuring MH and TH in Crohn's disease. Database records from 2012 to 2022 were searched for real-world evidence and interventional studies that reported the association of MH or TH with clinical, economic, or quality of life outcomes of adult patients with Crohn's disease. A total of 46 studies were identified in the systematic literature review, representing a combined patient population of 5530. Outcomes of patients with MH were reported by 39 studies; of these, 14 used validated scales for endoscopic assessment. Thirteen studies reported outcomes of patients with TH. Among studies that examined the outcomes of patients with and without MH or TH, patients with healing generally experienced improved clinical outcomes and reduced healthcare resource utilization, including fewer hospitalizations and surgeries and improved rates of clinical remission. This was especially true for patients with TH. Mucosal and transmural healing are associated with positive long-term outcomes for adult patients with Crohn's disease. The adoption of standardized measures and less invasive assessment tools will maximize the benefits of patient monitoring. Inflammation of the bowel wall is a key component of Crohn’s disease (CD). A systematic literature review (SLR) showed bowel wall healing was associated with positive long-term outcomes in CD, supporting healing as an indicator of disease control.

Sections du résumé

BACKGROUND BACKGROUND
Healing in Crohn's disease is complex and difficult to measure due to incongruencies between clinical symptoms and disease states. Mucosal healing (MH) and transmural healing (TH) are increasingly used to measure clinical improvement in Crohn's disease, but definitions of MH and TH can vary across studies, and their relationship to long-term outcomes is not clear. To address this knowledge gap, we performed a systematic literature review (SLR) to examine studies measuring MH and TH in Crohn's disease.
METHODS METHODS
Database records from 2012 to 2022 were searched for real-world evidence and interventional studies that reported the association of MH or TH with clinical, economic, or quality of life outcomes of adult patients with Crohn's disease.
RESULTS RESULTS
A total of 46 studies were identified in the systematic literature review, representing a combined patient population of 5530. Outcomes of patients with MH were reported by 39 studies; of these, 14 used validated scales for endoscopic assessment. Thirteen studies reported outcomes of patients with TH. Among studies that examined the outcomes of patients with and without MH or TH, patients with healing generally experienced improved clinical outcomes and reduced healthcare resource utilization, including fewer hospitalizations and surgeries and improved rates of clinical remission. This was especially true for patients with TH.
CONCLUSIONS CONCLUSIONS
Mucosal and transmural healing are associated with positive long-term outcomes for adult patients with Crohn's disease. The adoption of standardized measures and less invasive assessment tools will maximize the benefits of patient monitoring.
Inflammation of the bowel wall is a key component of Crohn’s disease (CD). A systematic literature review (SLR) showed bowel wall healing was associated with positive long-term outcomes in CD, supporting healing as an indicator of disease control.

Autres résumés

Type: plain-language-summary (eng)
Inflammation of the bowel wall is a key component of Crohn’s disease (CD). A systematic literature review (SLR) showed bowel wall healing was associated with positive long-term outcomes in CD, supporting healing as an indicator of disease control.

Identifiants

pubmed: 39083264
pii: 7724917
doi: 10.1093/ibd/izae159
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : AbbVie

Informations de copyright

© 2024 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.

Auteurs

Bruce E Sands (BE)

The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Silvio Danese (S)

Athos Therapeutics, Milan, Italy.
Humanitas University, Milan, Italy.

J Casey Chapman (JC)

GI Alliance, Dallas, Texas, USA.

Khushboo Gurjar (K)

Cytel Inc., Toronto, ON, Canada.

Stacy Grieve (S)

Cytel Inc., Toronto, ON, Canada.

Deepika Thakur (D)

Cytel Inc., Toronto, ON, Canada.

Jenny Griffith (J)

AbbVie Inc., North Chicago, Illinois, USA.

Namita Joshi (N)

AbbVie Inc., North Chicago, Illinois, USA.

Kristina Kligys (K)

AbbVie Inc., North Chicago, Illinois, USA.

Axel Dignass (A)

Department of Medicine, Agaplesion Markus Hospital, Frankfurt, Germany.

Classifications MeSH